Results 121 to 130 of about 29,491 (205)

Targeted depletion of activated fibroblasts via [¹⁷⁷Lu]Lu-FAPI radionuclide therapy ameliorates bleomycin-induced lung fibrosis. [PDF]

Front Immunol
Sun L, Li Z, Fang D, Zheng S, Deng H, Mu R.   +5 more
europepmc   +1 more source

Circulating Tumor DNA Monitoring in Peptide Receptor Radionuclide Therapy-Treated Patients With Gastroenteropancreatic Neuroendocrine Tumors. [PDF]

JCO Precis Oncol
Bogdani C, Karimi A, Li R, Atkinson EC, Oberstein PE, Siolas D.   +5 more
europepmc   +1 more source

Clinical Outcomes of Peptide Receptor Radionuclide Therapy in Japanese Patients with Metastatic Rectal Neuroendocrine Tumors. [PDF]

Cancers (Basel)
Iizuka T, Kobayashi N, Wild D, Kaul F, Suzuki H, Maehara K, Okubo N, Tsuyuki S, Takano S, Kurita Y, Yoneda M, Ichikawa Y.   +11 more
europepmc   +1 more source

Ablation-induced collagen exposure enables dual-modal nuclear imaging-guided local radionuclide therapy. [PDF]

J Nanobiotechnology
Wang P, Li N, Chen Q, Yao Y, Ren Y, Liu S, Hou X, Zhang B, Xiong F, Zhu X, Yang Z, Ni D, Yu B.   +12 more
europepmc   +1 more source

Management of Peptide Receptor Radionuclide Therapy Toxicities in Neuroendocrine Neoplasm Patients. [PDF]

Curr Treat Options Oncol
Mohindroo C, Ramirez RA.
europepmc   +1 more source

Bridging the gaps in fibroblast activation protein targeted radionuclide therapy: a translational perspective. [PDF]

Eur J Nucl Med Mol Imaging
Wu C, Kurniawan A, Ming Z, Antunes IF, Noordzij W, Glaudemans A, Cornelissen B.   +6 more
europepmc   +1 more source

Peptide receptor radionuclide therapy in neuroendocrine tumours: advances, combination strategies, and future directions. [PDF]

Eur J Nucl Med Mol Imaging
Virgolini IJ, Di Santo G, Santo G.
europepmc   +1 more source

Using advanced cell models for targeted radionuclide therapy evaluation: increased efficacy in 3D versus 2D. [PDF]

EJNMMI Res
Klomp MJ, Erkens SE, van den Brink L, van Weerden WM, Dalm SU.   +4 more
europepmc   +1 more source

Preclinical Evaluation of PTK7-Targeted Radionuclide Therapy. [PDF]

Mol Cancer Ther
Lindland K, Westrøm S, Dragovic SM, Li RG, Malenge MM, Ho B, Juzeniene A, Bønsdorff TB.   +7 more
europepmc   +1 more source

Linker Optimization in Lu-177 Labeled αvβ6-Integrin Binding Peptide Trimers for Targeted Radionuclide Therapy of Cancer. [PDF]

Mol Pharm
Nguyen NT, Rheinfrank T, Stangl S, Reissig F, Kossatz S, Notni J.   +5 more
europepmc   +1 more source